Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD

Chronic Obstr Pulm Dis. 2017 Jan 5;4(1):1-3. doi: 10.15326/jcopdf.4.1.2016.0175.
No abstract available

Keywords: LABAs; chronic obstructive pulmonary disease; copd; long-acting beta2-agonists.